{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "bad32605",
   "metadata": {},
   "source": [
    "# RAG Pipeline Exercise\n",
    "\n",
    "In this exercise you will build and **compare two simple Retrieval-Augmented Generation (RAG) pipelines**.\n",
    "\n",
    "You will work with a small collection of PDF documents (e.g. medical guidelines) and:\n",
    "\n",
    "1. Load and chunk the PDF documents.\n",
    "2. Create a vector index using **embedding model A** (local `BAAI/bge-m3`).\n",
    "3. Create a second index using **embedding model B** (e.g. OpenAI or Gemini embeddings).\n",
    "4. Implement a simple **retriever** and an **answering function** that calls an LLM with retrieved context.\n",
    "5. Automatically **generate questions** from the documents and use them to **compare two RAG configurations**.\n",
    "\n",
    "Cells marked with `# TODO` are **for students to implement**.\n",
    "Everything else is provided scaffolding."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ddf82e6",
   "metadata": {},
   "source": [
    "## 0. Setup & Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "be93ec53",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/python/3.12.1/lib/python3.12/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "# TODO (easy): skim the imports and make sure you understand what each library is used for.\n",
    "\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "import glob\n",
    "from PyPDF2 import PdfReader\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "import faiss\n",
    "from sentence_transformers import SentenceTransformer\n",
    "import pickle\n",
    "import random\n",
    "import numpy as np\n",
    "\n",
    "# LLM / API clients (we will mainly use OpenAI here; Gemini can be added as a bonus)\n",
    "from openai import OpenAI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "68f16980",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load API keys from .env (you need to create this file once and add your keys)\n",
    "load_dotenv()\n",
    "\n",
    "deepinfra_key = os.getenv(\"DEEPINFRA_API_KEY\")\n",
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "google_api_key = os.getenv(\"GOOGLE_API_KEY\")\n",
    "anthropic_api_key = os.getenv(\"ANTHROPIC_API_KEY\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fba2719d",
   "metadata": {},
   "source": [
    "## 1. Load PDF documents\n",
    "\n",
    "We assume there is a `data/` folder containing one or more PDF files.\n",
    "\n",
    "**Task:** implement `load_pdfs(glob_path)` so that it:\n",
    "- Iterates over all PDF files matching `glob_path`\n",
    "- Reads them with `PdfReader`\n",
    "- Concatenates the text of all pages into **one long string**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d8abcb21",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_pdfs(glob_path: str = \"data/*.pdf\") -> str:\n",
    "    \"\"\"Load all PDFs matching the pattern and return their combined text.\n",
    "\n",
    "    - Use `glob.glob(glob_path)` to iterate over file paths\n",
    "    - For each file, open it in binary mode and create a `PdfReader`\n",
    "    - Loop over `reader.pages` and extract text with the extract_text() function\n",
    "    - Concatenate everything into a single string `text`\n",
    "    - Be robust: skip pages where `extract_text()` returns None\n",
    "    \"\"\"\n",
    "    text = \"\"\n",
    "    for pdf_path in glob.glob(glob_path):\n",
    "        try:\n",
    "            with open(pdf_path, \"rb\") as f:\n",
    "                reader = PdfReader(f)\n",
    "                for page in reader.pages:\n",
    "                    page_text = page.extract_text()\n",
    "                    if page_text:\n",
    "                        text += page_text\n",
    "        except Exception as e:\n",
    "            print(\"Warning: could not read PDF file\", pdf_path, e)\n",
    "    return text\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "416c3ad0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of characters: 230592\n",
      "Preview: Asthma: diagnosis, \n",
      "moni toring and chr onic \n",
      "asthma manag emen t (BTS, \n",
      "NICE, SI GN) \n",
      "NICE guideline \n",
      "Published: 27 No vember 202 4 \n",
      "www .nice.or g.uk/guidance/ng2 45 \n",
      "© NICE 202 4. All right s reserved. Subject t o Notice of right s (https://www .nice.or g.uk/t erms-and-\n",
      "conditions#notice-of -right s).Your r esponsi bility \n",
      "The r ecommendations in t his guideline r epresent t he view of NICE, arriv ed at aft er car eful \n",
      "consideration of t he evidence a vailable. When e xercising t heir judgem\n"
     ]
    }
   ],
   "source": [
    "# Run once and inspect\n",
    "raw_text = load_pdfs(\"data/*.pdf\")\n",
    "print(\"Number of characters:\", len(raw_text))\n",
    "print(\"Preview:\", raw_text[:500])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c0c5a14",
   "metadata": {},
   "source": [
    "## 2. Chunk the text\n",
    "\n",
    "We will split the long text into overlapping chunks.\n",
    "\n",
    "Later you can **experiment** with different `chunk_size` and `chunk_overlap` to see how it affects retrieval.\n",
    "\n",
    "**Task:** start with the given parameters, run once, then try at least one alternative configuration and note the effects."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "a4e3f802",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG A: 129 chunks produced, first chunk length = 1994\n",
      "RAG B: 592 chunks produced, first chunk length = 519\n"
     ]
    }
   ],
   "source": [
    "# Base configuration (RAG A)\n",
    "chunk_size_a = 2000\n",
    "chunk_overlap_a = 200\n",
    "\n",
    "splitter_a = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_a,\n",
    "    chunk_overlap=chunk_overlap_a\n",
    ")\n",
    "\n",
    "chunks_a = splitter_a.split_text(raw_text)\n",
    "print(f\"RAG A: {len(chunks_a)} chunks produced, first chunk length = {len(chunks_a[0])}\")\n",
    "\n",
    "# TODO (mini-experiment): change chunk_size / chunk_overlap for RAG B and compare\n",
    "chunk_size_b = 600   # e.g. smaller chunks\n",
    "chunk_overlap_b = 200\n",
    "\n",
    "splitter_b = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_b,\n",
    "    chunk_overlap=chunk_overlap_b\n",
    ")\n",
    "\n",
    "chunks_b = splitter_b.split_text(raw_text)\n",
    "print(f\"RAG B: {len(chunks_b)} chunks produced, first chunk length = {len(chunks_b[0])}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec3511f4",
   "metadata": {},
   "source": [
    "## 3. Create embeddings and a FAISS index\n",
    "\n",
    "We start with **Embedding model A: `BAAI/bge-small-en`** using `sentence-transformers`. You can find a list of more models here: https://huggingface.co/spaces/mteb/leaderboard \n",
    "make sure that the models are not bigger than the one used here. Otherwise the embeddings process will take too long.\n",
    "\n",
    "Then, as an optional extension, you can build **Embedding model B** using OpenAI or Gemini and compare.\n",
    "\n",
    "To keep the exercise manageable, the base version only **requires** BGE."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b519161f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Embedding dimensionality (A): 384\n",
      "FAISS index (A) size: 129\n"
     ]
    }
   ],
   "source": [
    "# Embedding model A (local)\n",
    "model_name_a = \"BAAI/bge-small-en\"\n",
    "embedder_a = SentenceTransformer(model_name_a)\n",
    "\n",
    "# Compute embeddings for all chunks of configuration A\n",
    "embeddings_a = embedder_a.encode(chunks_a, convert_to_numpy=True)\n",
    "\n",
    "dimensions_a = embeddings_a.shape[1]\n",
    "print(\"Embedding dimensionality (A):\", dimensions_a)\n",
    "\n",
    "index_a = faiss.IndexFlatL2(dimensions_a)\n",
    "index_a.add(embeddings_a)\n",
    "print(\"FAISS index (A) size:\", index_a.ntotal)\n",
    "\n",
    "# Persist index/chunks if you like (optional)\n",
    "os.makedirs(\"faiss\", exist_ok=True)\n",
    "faiss.write_index(index_a, \"faiss/faiss_index_a.index\")\n",
    "with open(\"faiss/chunks_a.pkl\", \"wb\") as f:\n",
    "    pickle.dump(chunks_a, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "77271916",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FAISS index (B) size: 592\n"
     ]
    }
   ],
   "source": [
    "# Embedding model B using OpenAI embeddings.\n",
    "\n",
    "# TODO :\n",
    "# - Use `openai_client.embeddings.create(...)` to compute embeddings for `chunks_b`\n",
    "# - Create a second FAISS index `index_b`\n",
    "# - Make sure to check the dimensionality from the first embedding vector\n",
    "\n",
    "\n",
    "openai_client = OpenAI(api_key=openai_api_key)\n",
    "response = openai_client.embeddings.create(\n",
    "     model=\"text-embedding-3-small\",\n",
    "    input=chunks_b\n",
    ")\n",
    "embeddings_b = np.array([item.embedding for item in response.data])\n",
    "dim_b = embeddings_b.shape[1]\n",
    "index_b = faiss.IndexFlatL2(dim_b)\n",
    "\n",
    "index_b.add(embeddings_b)\n",
    "print(\"FAISS index (B) size:\", index_b.ntotal)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0339224e",
   "metadata": {},
   "source": [
    "## 4. Implement a simple retriever\n",
    "\n",
    "We now implement a generic retrieval function that:\n",
    "1. Embeds the query.\n",
    "2. Searches the FAISS index.\n",
    "3. Returns the corresponding text chunks.\n",
    "\n",
    "We implement it for configuration A. If you built configuration B, you can reuse the same function."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "aa6fbf82",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of retrieved chunks: 3\n",
      "Preview of first chunk: specialist. [NICE 2017] \n",
      "1.5 M onitoring asthma c ontrol \n",
      "1.5.1 Monit or asthma contr ol at every review . In addition t o asking about sympt oms, \n",
      "check: \n",
      "• time off w ork or school due t o ast hma \n",
      "• amount of r eliever inhaler used, including a check of t he pr escription r ecord \n",
      "• number of courses of oral cor ticost eroids \n",
      "• any admissions t o hospital or att endance at an emer gency depar tment due \n",
      "to ast hma. \n",
      "If contr ol is suboptimal, see recommendation 1 .6.1 in t he section on principles \n",
      "of pharmacological tr eatment . [BTS/NICE/SIGN 202 4] \n",
      "1.5.2 Consider using a v alidat ed sympt om questionnair e (for example, t he Ast hma \n",
      "Contr ol Questionnair e, the Ast hma Contr ol Test or t he Childhood Ast hma Contr ol \n",
      "Test) at an y ast hma r eview . [BTS/NICE/SIGN 202 4] \n",
      "1.5.3 Do not use r egular peak e xpirat ory flow (PEF) monit oring t o assess ast hma \n",
      "contr ol unless t here are person-specific r easons f or doing so (f or example, when \n",
      "PEF measur ement is par t of t he personalised ast hma action plan). [BTS/NICE/\n",
      "SIGN 202 4] \n",
      "1.5.4 Consider fractional e xhaled nitric o xide (F eNO) monit oring f or adult s wit h ast hma: \n",
      "• at their r egular r eview , and \n",
      "• before and aft er changing t heir ast hma t herap y. [BTS/NICE/SIGN 202 4] Asthma: diagnosis, monit oring and chr onic ast hma management (BTS, NICE, SIGN)\n",
      "(NG2 45)\n",
      "© NICE 202 4. All right s reserved. Subject t o Notice of right s (https://www .nice.or g.uk/t erms-and-\n",
      "conditions#notice-of -right s).Page 15 of\n",
      "64For a shor t explanation of wh y the committ ee made t hese r ecommendations and ho w \n",
      "they might aff ect practice, see t he rationale and impact section on monit oring ast hma \n",
      "contr ol. \n",
      "Full details of t he evidence and t he committ ee's discussion ar e in: \n",
      "• evidence r eview L: sympt om diar y for monit oring ast hma \n",
      "• evidence r eview  M: pulmonar y function monit oring in ast hma \n",
      "• evidence r eview  N: FeNO measur es to monit or ast hma.\n"
     ]
    }
   ],
   "source": [
    "def retrieve_texts(query: str, k: int, index, chunks, embedder) -> list:\n",
    "    \"\"\"Return the top-k most similar chunks for a query.\n",
    "    - Encode the query with `embedder.encode(...)`\n",
    "    - Call `index.search(query_embedding, k)`\n",
    "    - Use the returned indices to select the chunks\n",
    "    - Return a list of strings (chunks)\n",
    "    \"\"\"\n",
    "    # YOUR CODE HERE\n",
    "    query_emb = embedder.encode([query], convert_to_numpy=True)\n",
    "    distances, indices = index.search(query_emb, k)\n",
    "    retrieved = [chunks[i] for i in indices[0]]\n",
    "    return retrieved\n",
    "\n",
    "# Quick sanity check\n",
    "test_query = \"What is the most important factor in diagnosing asthma?\"\n",
    "retrieved_test = retrieve_texts(test_query, 3, index_a, chunks_a, embedder_a)\n",
    "print(\"Number of retrieved chunks:\", len(retrieved_test))\n",
    "print(\"Preview of first chunk:\", retrieved_test[1] )"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f646fdc6",
   "metadata": {},
   "source": [
    "## 5. Implement `answer_query` using an LLM\n",
    "\n",
    "Now we build the actual RAG call:\n",
    "\n",
    "1. Use `retrieve_texts` to get top-`k` chunks.\n",
    "2. Concatenate them into a context string.\n",
    "3. Build a prompt that:\n",
    "   - shows the context\n",
    "   - asks the model to answer the user question based **only** on this context.\n",
    "4. Call the OpenAI chat completion API.\n",
    "\n",
    "This is the **core RAG function**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "0d94610c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG answer: The most important factor in diagnosing asthma is a thorough patient history and assessment of symptoms. Key indicators include:\n",
      "\n",
      "1. **Medical History**: A detailed account of the patient's symptoms, including their frequency and severity. This often includes questions about wheezing, coughing (especially at night or after exercise), shortness of breath, and chest tightness.\n",
      "\n",
      "2. **Symptom Patterns**: Understanding when symptoms occur, such as whether they are triggered by specific allergens, exercise, or illnesses, is crucial.\n",
      "\n",
      "3. **Physical Examination**: A physical exam can provide information about wheezing or other respiratory issues.\n",
      "\n",
      "4. **Pulmonary Function Tests**: These tests, such as spirometry, measure how well the lungs are working and can help assess airway obstruction.\n",
      "\n",
      "5. **Response to Medications**: Improvement of symptoms with bronchodilators can support an asthma diagnosis.\n",
      "\n",
      "Overall, a combination of clinical history, symptom examination, and diagnostic testing is vital for an accurate diagnosis of asthma.\n"
     ]
    }
   ],
   "source": [
    "def answer_query(query: str, k: int, index, chunks, embedder, client: OpenAI) -> str:\n",
    "    \"\"\"RAG-style answer: retrieve context and ask an LLM.\n",
    "\n",
    "    TODO (students):\n",
    "    - Use `retrieve_texts` to get `k` relevant chunks.\n",
    "    - Join them into a single context string.\n",
    "    - Build a chat prompt that instructs the model to answer *only* using the context.\n",
    "    - Call `client.chat.completions.create(...)` with model `\"gpt-5o-mini\"` (or similar).\n",
    "    - Return the model's answer text.\n",
    "    \"\"\"\n",
    "    retrieved_chunks = retrieve_texts(query, k, index, chunks, embedder)\n",
    "    context = \"join(retrieved_chunks)\"\n",
    "\n",
    "    # Remember: strings can be concatenated (like an addition)\n",
    "    system_prompt = (\n",
    "        \"What are you studying?\"\n",
    "    )\n",
    "\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": f\"Context: {context}\\n\\nQuestion: {query}\"}\n",
    "    ]\n",
    "\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=messages\n",
    "    )\n",
    "\n",
    "    return completion.choices[0].message.content.strip()\n",
    "\n",
    "# Quick manual test\n",
    "answer = answer_query(test_query, k=3, index=index_a, chunks=chunks_a, embedder=embedder_a, client=openai_client)\n",
    "print(\"RAG answer:\", answer)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a86a92e",
   "metadata": {},
   "source": [
    "## 6. Generate questions from random chunks (automatic evaluation set)\n",
    "\n",
    "To compare two RAG configurations, we need **questions**.\n",
    "\n",
    "We will:\n",
    "- randomly sample a few chunks from the corpus,\n",
    "- ask an LLM to generate a **good question** whose answer is contained in the chunk.\n",
    "\n",
    "Then we can use these question–chunk pairs as a small evaluation set.\n",
    "\n",
    "We provide most of the implementation. Your job is mainly to:\n",
    "- inspect the code,\n",
    "- understand the prompt,\n",
    "- maybe tweak the number of chunks or retries."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "eb899fb6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Q1: What are the recommended methods for monitoring asthma control as outlined in the text, and under what circumstances should specific tools like questionnaires or fractional exhaled nitric oxide (FeNO) be utilized?\n",
      "  From chunk preview: specialist. [NICE 2017] \n",
      "1.5 M onitoring asthma c ontrol \n",
      "1.5.1 Monit or asthma contr ol at every review . In addition t...\n",
      "\n",
      "Q2: What are the key differences in efficacy and safety between as-needed combination inhalers (ICS and LABA) and traditional SABA or ICS plus SABA treatments for newly diagnosed asthma patients, and how might these findings influence clinical practice?\n",
      "  From chunk preview: over wit h a new diagnosis of ast hma. These w ere SABA as needed wit h no ICS; r egular \n",
      "low-dose ICS plus SABA as need...\n",
      "\n",
      "Q3: What considerations did the committee discuss regarding the differentiation between accelerated and severe hypertension, and how did they propose to improve referral and treatment protocols based on their findings?\n",
      "  From chunk preview: review ed the 2011 r ecommendations and agr eed t hat t hey should be updat ed by \n",
      "consensus based on t heir clinical e ...\n",
      "\n",
      "Q4: What are the diagnostic criteria and methods for confirming asthma in adults and children based on eosinophil count, fractional exhaled nitric oxide levels, and bronchodilator reversibility?\n",
      "  From chunk preview: conditions#notice-of -right s).Page 10 of\n",
      "641.2.1 Measur e the blood eosinophil count  or fractional e xhaled nitric o x...\n",
      "\n",
      "Q5: What are the key considerations and recommendations for ensuring proper inhaler technique and management in individuals with asthma, as outlined in the recent guidelines?\n",
      "  From chunk preview: include t he medicines t hey contain, ho w they work, when t hey should be tak en \n",
      "and t he corr ect t echnique t o use ...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def generate_questions_for_random_chunks(chunks, num_chunks: int = 5, max_retries: int = 2):\n",
    "    selected_chunks = random.sample(chunks, num_chunks)\n",
    "    qa_pairs = []\n",
    "\n",
    "    for chunk in selected_chunks:\n",
    "        prompt = prompt = (\n",
    "            \"Based on the following text, generate an insightful question that covers its key content:\\n\\n\"\n",
    "            \"Text:\\n\" + chunk + \"\\n\\n\"\n",
    "            \"Question:\"\n",
    "        )\n",
    "\n",
    "        question = None\n",
    "        for attempt in range(max_retries):\n",
    "            try:\n",
    "                completion = openai_client.chat.completions.create(\n",
    "                    model=\"gpt-4o-mini\",\n",
    "                    messages=[{\"role\": \"user\", \"content\": prompt}]\n",
    "                )\n",
    "                question = completion.choices[0].message.content.strip()\n",
    "                if question:\n",
    "                    break\n",
    "            except Exception as e:\n",
    "                print(\"Error while generating question, retrying...\", e)\n",
    "\n",
    "        if question is None:\n",
    "            question = \"Error: could not generate question.\"\n",
    "\n",
    "        qa_pairs.append((chunk, question))\n",
    "\n",
    "    return qa_pairs\n",
    "\n",
    "questions = generate_questions_for_random_chunks(chunks_a, num_chunks=5, max_retries=2)\n",
    "for i, (chunk, q) in enumerate(questions, 1):\n",
    "    print(f\"Q{i}: {q}\\n  From chunk preview: {chunk[:120]}...\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3fd0eaf5",
   "metadata": {},
   "source": [
    "## 7. Compare two RAG configurations\n",
    "\n",
    "Now we can:\n",
    "- Use the generated questions,\n",
    "- Answer them with RAG configuration A (BGE + chunking A),\n",
    "- (Optional) Answer them with RAG configuration B (e.g. different chunking and/or different embeddings),\n",
    "- Compare the answers qualitatively.\n",
    "\n",
    "To keep the exercise manageable, we start with config A only.\n",
    "If you implemented config B, reuse `answer_query` with `index_b`, `chunks_b`, and your second embedder."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "a292474a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Question: What are the recommended methods for monitoring asthma control as outlined in the text, and under what circumstances should specific tools like questionnaires or fractional exhaled nitric oxide (FeNO) be utilized?\n",
      "Answer A: The recommended methods for monitoring asthma control typically include a combination of clinical assessments, patient self-reports, and objective measurements. Key methods include:\n",
      "\n",
      "1. **Symptom Questionnaires**: Tools such as the Asthma Control Questionnaire (ACQ) or Asthma Control Test (ACT) can be used regularly to assess the patient's symptoms and control over time. These are particularly useful during regular follow-up visits or when there is a need to evaluate changes due to treatment adjustments or exacerbations.\n",
      "\n",
      "2. **Peak Expiratory Flow Measurement**: Patients may be encouraged to use a peak flow meter to monitor their lung function at home. This tool is helpful for those with more severe asthma or those who experience frequent fluctuations in their condition.\n",
      "\n",
      "3. **Fractional Exhaled Nitric Oxide (FeNO)**: This measurement can be used to assess airway inflammation. FeNO is particularly useful in patients who have difficulty with symptom control, experience frequent exacerbations, or when there is a need to evaluate adherence to inhaled corticosteroid therapy.\n",
      "\n",
      "4. **Medication Adherence Monitoring**: Regular discussions about medication use and adherence can help identify issues that may affect asthma control.\n",
      "\n",
      "Specific tools like questionnaires or FeNO measurements should be utilized under the following circumstances:\n",
      "\n",
      "- **Questionnaires**: These are best used for routine assessments and when determining if a patient's symptoms are well-controlled or when adjustments to treatment are necessary.\n",
      "  \n",
      "- **FeNO Measurement**: This should be considered in situations where there is uncertainty about the diagnosis, in patients with uncontrolled asthma despite treatment, or when confirming the presence of eosinophilic airway inflammation, which can guide treatment decisions, especially regarding corticosteroid use.\n",
      "\n",
      "Overall, the choice of monitoring tools should be tailored to the individual patient’s needs, asthma severity, and existing treatment plan.\n",
      "Source chunk preview: specialist. [NICE 2017] \n",
      "1.5 M onitoring asthma c ontrol \n",
      "1.5.1 Monit or asthma contr ol at every review . In addition t o asking about sympt oms, \n",
      "ch ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the key differences in efficacy and safety between as-needed combination inhalers (ICS and LABA) and traditional SABA or ICS plus SABA treatments for newly diagnosed asthma patients, and how might these findings influence clinical practice?\n",
      "Answer A: The key differences in efficacy and safety between as-needed combination inhalers (which include inhaled corticosteroids [ICS] and long-acting beta agonists [LABA]) and traditional treatments (such as short-acting beta agonists [SABA] or ICS plus SABA) for newly diagnosed asthma patients are as follows:\n",
      "\n",
      "### Efficacy:\n",
      "1. **Symptom Control**: As-needed combination inhalers demonstrate improved symptom control compared to SABA alone. They provide more comprehensive management of asthma by addressing both inflammation (via ICS) and bronchoconstriction (via LABA).\n",
      "\n",
      "2. **Reduction in Exacerbations**: Studies have shown that as-needed combination inhalers can effectively reduce the frequency of asthma exacerbations compared to SABA or ICS plus SABA treatments. They offer a proactive approach to asthma management.\n",
      "\n",
      "3. **Improvement in Lung Function**: Patients using as-needed combination inhalers may experience better overall lung function and control of asthma symptoms, leading to improved quality of life and reduced use of rescue medications.\n",
      "\n",
      "### Safety:\n",
      "1. **Side Effects**: As-needed combination inhalers may have different side effect profiles compared to traditional therapies. For instance, LABAs can carry a risk of increased cardiovascular events in some cases, though this risk is generally low and needs to be balanced with their benefits.\n",
      "\n",
      "2. **Adrenal Suppression and Growth**: Long-term use of ICS (even as part of a combination inhaler) has been associated with potential adrenal suppression and effects on growth in children, although these risks are generally considered manageable with careful monitoring.\n",
      "\n",
      "3. **Development of Tolerance**: With traditional SABA therapy, patients might develop tolerance, leading to decreased efficacy over time, whereas as-needed combination inhalers aim to mitigate this risk due to the additive effects of the ICS.\n",
      "\n",
      "### Clinical Practice Implications:\n",
      "- **Shift in Treatment Paradigm**: The findings may prompt healthcare providers to consider as-needed combination inhalers as first-line therapy for newly diagnosed asthma patients, particularly for those experiencing moderate to severe symptoms, rather than relying solely on SABA or ICS plus SABA.\n",
      "\n",
      "- **Personalized Treatment Plans**: The enhanced efficacy and safety profiles of as-needed combination inhalers might encourage the adoption of more personalized approaches in asthma management, tailoring treatments based on individual patient needs and response.\n",
      "\n",
      "- **Patient Education**: Clinicians might focus on educating patients regarding the benefits of using combination inhalers, emphasizing how they can manage acute symptoms while also providing long-term control of inflammation.\n",
      "\n",
      "- **Monitoring and Follow-up**: There may be an increased emphasis on regular follow-up with patients using combination therapies to evaluate effectiveness and make adjustments as needed, ensuring optimal control of asthma symptoms and minimizing the risk of exacerbations or side effects.\n",
      "\n",
      "In summary, as-needed combination inhalers appear to offer enhanced efficacy and safety profiles compared to traditional SABA or ICS plus SABA treatments, influencing clinical practice by guiding initial treatment choices and shaping ongoing management strategies for newly diagnosed asthma patients.\n",
      "Source chunk preview: over wit h a new diagnosis of ast hma. These w ere SABA as needed wit h no ICS; r egular \n",
      "low-dose ICS plus SABA as needed; and a combination inhaler  ...\n",
      "------------------------------------------------------------\n",
      "Question: What considerations did the committee discuss regarding the differentiation between accelerated and severe hypertension, and how did they propose to improve referral and treatment protocols based on their findings?\n",
      "Answer A: The committee discussed several key considerations regarding the differentiation between accelerated and severe hypertension. They noted that while both conditions involve critically high blood pressure levels, their underlying mechanisms, patient presentations, and risks of complications can differ significantly. Accelerated hypertension typically involves a more gradual increase in blood pressure with evidence of organ damage, while severe hypertension is characterized by more immediate health threats.\n",
      "\n",
      "To improve referral and treatment protocols, the committee proposed the following actions:\n",
      "\n",
      "1. **Clear Definitions**: Establish standardized definitions of accelerated and severe hypertension to ensure consistent diagnosis and treatment across healthcare providers.\n",
      "\n",
      "2. **Enhanced Training**: Implement educational programs for healthcare professionals to better recognize the symptoms and risks associated with both types of hypertension.\n",
      "\n",
      "3. **Referral Pathways**: Develop clear referral pathways that guide practitioners on when and how to refer patients to specialists based on their specific hypertension classification.\n",
      "\n",
      "4. **Protocols for Monitoring**: Propose protocols for regular monitoring and follow-up care tailored to the severity of hypertension and any accompanying complications.\n",
      "\n",
      "5. **Patient Education**: Create materials to educate patients on the importance of understanding their condition, recognizing warning signs, and adhering to treatment plans.\n",
      "\n",
      "6. **Research Initiatives**: Encourage further research into the long-term outcomes of patients with accelerated versus severe hypertension to refine treatment approaches and improve overall care.\n",
      "\n",
      "By addressing these considerations, the committee aimed to enhance patient outcomes through timely and appropriate intervention strategies tailored to the specific type of hypertension experienced by patients.\n",
      "Source chunk preview: review ed the 2011 r ecommendations and agr eed t hat t hey should be updat ed by \n",
      "consensus based on t heir clinical e xper tise. In par ticular t he ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the diagnostic criteria and methods for confirming asthma in adults and children based on eosinophil count, fractional exhaled nitric oxide levels, and bronchodilator reversibility?\n",
      "Answer A: The diagnostic criteria for asthma in both adults and children typically involve a combination of clinical history, physical examination, and complementary tests. Here are the criteria and methods for confirming asthma, referencing eosinophil count, fractional exhaled nitric oxide (FeNO) levels, and bronchodilator reversibility:\n",
      "\n",
      "### 1. Clinical History and Symptoms\n",
      "- **Symptoms:** Persistent cough, wheezing, shortness of breath, and chest tightness, especially if they vary over time and in intensity.\n",
      "- **Triggers:** Identification of specific triggers (e.g., allergens, exercise, cold air) that can exacerbate symptoms.\n",
      "\n",
      "### 2. Physical Examination\n",
      "- **Respiratory Examination:** May reveal wheezing or prolonged expiration during auscultation.\n",
      "\n",
      "### 3. Spirometry\n",
      "- **Baseline Spirometry:** Measures forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). An FEV1/FVC ratio of less than 0.70 indicates airflow obstruction.\n",
      "- **Bronchodilator Reversibility Test:** Administer a bronchodilator and re-evaluate spirometry. An increase in FEV1 of 12% or more and at least 200 mL from baseline suggests reversible airflow obstruction, characteristic of asthma.\n",
      "\n",
      "### 4. Eosinophil Count\n",
      "- **Blood Eosinophil Count:** Elevated eosinophils (typically >300 cells/µL) are often associated with asthma and can indicate eosinophilic airway inflammation.\n",
      "- **Sputum Eosinophils:** Sputum samples can be analyzed for eosinophil levels, with a high percentage indicating eosinophilic asthma.\n",
      "\n",
      "### 5. Fractional Exhaled Nitric Oxide (FeNO)\n",
      "- **FeNO Measurement:** Elevated FeNO levels (usually ≥ 25 parts per billion for adults and ≥ 20 parts per billion for children) suggest eosinophilic airway inflammation and are helpful in diagnosing asthma and monitoring treatment.\n",
      "\n",
      "### 6. Additional Tests (if needed)\n",
      "- **Peak Expiratory Flow Rate (PEFR):** Monitoring variability in PEFR can support a diagnosis of asthma.\n",
      "- **Allergy Testing:** Skin prick tests or serum specific IgE tests can help identify atopic asthma.\n",
      "\n",
      "### Conclusion\n",
      "The diagnosis of asthma is based on a comprehensive assessment of history, clinical examination, and supportive testing. Elevated eosinophil counts and FeNO levels, in conjunction with reversible airflow obstruction demonstrated by spirometry post-bronchodilator, reinforce the diagnosis of asthma. Always consider repeating tests and monitoring responses to treatment to confirm the diagnosis.\n",
      "Source chunk preview: conditions#notice-of -right s).Page 10 of\n",
      "641.2.1 Measur e the blood eosinophil count  or fractional e xhaled nitric o xide (F eNO) le vel \n",
      "in adult s ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the key considerations and recommendations for ensuring proper inhaler technique and management in individuals with asthma, as outlined in the recent guidelines?\n",
      "Answer A: Key considerations and recommendations for ensuring proper inhaler technique and management in individuals with asthma, based on recent guidelines, typically include the following:\n",
      "\n",
      "1. **Inhaler Technique Education**:\n",
      "   - Ensure patients receive detailed training on the correct use of their specific inhaler device, as different types may have varying techniques.\n",
      "   - Provide visual aids or demonstrations to reinforce proper technique.\n",
      "   - Assess and confirm the patient's understanding of inhaler use during follow-up appointments.\n",
      "\n",
      "2. **Regular Review of Technique**:\n",
      "   - Schedule regular assessments of inhaler technique to identify and correct any issues.\n",
      "   - Encourage patients to demonstrate their inhaler technique during consultations.\n",
      "\n",
      "3. **Use of Spacer Devices**:\n",
      "   - Recommend the use of spacer devices with metered-dose inhalers (MDIs) to enhance medication delivery to the lungs and reduce oropharyngeal side effects.\n",
      "   - Educate patients on the proper use of spacers.\n",
      "\n",
      "4. **Medication Management**:\n",
      "   - Regularly review medication regimens to ensure they are appropriate for the individual’s asthma control level.\n",
      "   - Discuss the importance of adherence to prescribed therapy and address any barriers to compliance.\n",
      "\n",
      "5. **Assessing Control**:\n",
      "   - Use standardized tools and questionnaires to assess asthma control, such as the Asthma Control Test (ACT) or the Asthma Score.\n",
      "   - Adjust treatment based on control levels, ensuring a stepwise approach according to guideline recommendations.\n",
      "\n",
      "6. **Action Plan Development**:\n",
      "   - Collaborate with patients to create personalized asthma action plans that outline daily management and what to do in case of worsening symptoms.\n",
      "   - Ensure patients know when and how to seek assistance during exacerbations.\n",
      "\n",
      "7. **Triggers and Environmental Control**:\n",
      "   - Help patients identify and manage asthma triggers (e.g., allergens, smoke, pollution) in their environment.\n",
      "   - Provide strategies to minimize exposure to known triggers.\n",
      "\n",
      "8. **Education on Comorbidities**:\n",
      "   - Address comorbid conditions that may affect asthma management, such as allergic rhinitis, obesity, or gastroesophageal reflux disease (GERD).\n",
      "   - Ensure a holistic approach to treatment that considers overall health.\n",
      "\n",
      "9. **Follow-Up and Reassessment**:\n",
      "   - Schedule regular follow-ups to monitor asthma control and inhaler technique.\n",
      "   - Utilize telehealth options for follow-up visits if applicable.\n",
      "\n",
      "10. **Patient Involvement**:\n",
      "   - Engage patients actively in their care, encouraging them to take ownership of their asthma management.\n",
      "   - Provide support and resources through patient groups or educational materials.\n",
      "\n",
      "By implementing these considerations, healthcare providers can significantly enhance the management of asthma in their patients, leading to improved outcomes and overall quality of life.\n",
      "Source chunk preview: include t he medicines t hey contain, ho w they work, when t hey should be tak en \n",
      "and t he corr ect t echnique t o use f or each de vice. [BTS/SIGN 2 ...\n",
      "------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "def answer_generated_questions(question_tuples, k, index, chunks, embedder, client):\n",
    "    results = []\n",
    "    for chunk, question in question_tuples:\n",
    "        answer = answer_query(question, k, index, chunks, embedder, client)\n",
    "        results.append({\n",
    "            \"chunk\": chunk,\n",
    "            \"question\": question,\n",
    "            \"answer\": answer\n",
    "        })\n",
    "    return results\n",
    "\n",
    "results_a = answer_generated_questions(\n",
    "    questions,\n",
    "    k=5,\n",
    "    index=index_a,\n",
    "    chunks=chunks_a,\n",
    "    embedder=embedder_a,\n",
    "    client=openai_client,\n",
    ")\n",
    "\n",
    "for item in results_a:\n",
    "    print(\"Question:\", item[\"question\"])\n",
    "    print(\"Answer A:\", item[\"answer\"])\n",
    "    print(\"Source chunk preview:\", item[\"chunk\"][:150], \"...\")\n",
    "    print(\"-\" * 60)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2ec212b7",
   "metadata": {},
   "source": [
    "Add RAG B and create a comparison table\n",
    "\n",
    "If you implemented a second configuration (e.g. different chunking + OpenAI embeddings):\n",
    "\n",
    "1. Build `index_b` and `embedder_b`.\n",
    "2. Run `results_b = answer_generated_questions(..., index_b, chunks_b, embedder_b, client)`.\n",
    "3. For each question, compare:\n",
    "   - Which answer is more complete / specific?\n",
    "   - Which one is better grounded in the source chunk?\n",
    "4. Summarise your findings in a short **markdown cell** or a small table.\n",
    "\n",
    "---\n",
    "\n",
    "This concludes the core RAG exercise."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3cda81a3",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
